Intelligence · Clinical Pipeline
Eli Lilly and Pipeline
All ClinicalTrials.gov programs at Eli Lilly and — phase, modality, and trial IDs.
- Programs
- 62
Quick answer
Eli Lilly and has 62 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
LY3532226
Eli Lilly and Company
Obesity
1 trial -
LY3537021
Eli Lilly and Company
Healthy
1 trial -
LY3819469
Eli Lilly and Company
Healthy
1 trial -
LY4006896
Eli Lilly and Company
Parkinson Disease
1 trial -
Olaratumab
Eli Lilly and Company
Malignancy
1 trial -
Olomorasib
Eli Lilly and Company
Healthy
1 trial -
Tabalumab
Eli Lilly and Company
Multiple Myeloma
1 trial -
Tirzepatide
Eli Lilly and Company
Healthy
1 trial -
Abemaciclib
Eli Lilly and Company
Breast Neoplasms
1 trial -
Abemaciclib
Eli Lilly and Company
Metastatic Breast Cancer
1 trial -
Insulin Glargine
Eli Lilly and Company
Diabetes Mellitus, Type 2
1 trial -
Insulin lispro low mixture
Eli Lilly and Company
Type 2 Diabetes Mellitus
1 trial -
premeal insulin lispro mixtures
Eli Lilly and Company
Diabetes Mellitus, Type 2
1 trial -
Propranolol
Eli Lilly and Company
Healthy
1 trial
Frequently asked questions
How many pipeline programs does Eli Lilly and have?
62 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs